Welcome to the UPF Digital Repository

Pityriasis rubra pilaris: a multicentric case series of 65 spanish patients

Show simple item record

dc.contributor.author Montero Menárguez, Julia
dc.contributor.author Amat Samaranch, Victoria
dc.contributor.author Puig Sanz, Lluís
dc.contributor.author Ruiz Villaverde, Ricardo
dc.contributor.author Arias Santiago, Salvador
dc.contributor.author Larrea García, Mónica
dc.contributor.author Ruiz Genao, Diana
dc.contributor.author Ferran Farrés, Marta
dc.contributor.author Schneller-Pavelescu, Luca
dc.contributor.author Romero Ferreiro, Carmen
dc.contributor.author Rivera Díaz. Raquel
dc.date.accessioned 2024-09-26T06:19:24Z
dc.date.available 2024-09-26T06:19:24Z
dc.date.issued 2024
dc.identifier.citation Montero-Menárguez J, Amat Samaranch V, Puig Sanz L, Ruiz-Villaverde R, Arias-Santiago S, Larrea García M, et al. Pityriasis rubra pilaris: a multicentric case series of 65 spanish patients. Actas Dermosifiliogr. 2024 Sep;115(8):t761-t5. DOI: 10.1016/j.ad.2024.02.019
dc.identifier.issn 0001-7310
dc.identifier.uri http://hdl.handle.net/10230/61230
dc.description Article disponible en castellà: http://hdl.handle.net/10230/61229
dc.description.abstract Introduction: PRP is a rare entity of unknown etiopathogenesis. Lack of management guidelines makes it a challenge for clinicians. Objective: To add our experience to increase evidence about PRP. Methods: We performed a retrospective, descriptive and multicentric study of 65 patients with PRP, being the largest European case series of patients with PRP. Results: PRP was more frequent in male patients with an average age of 51 years, but erythrodermic forms presented in older patients (average age 61 years). Six (75%) paediatric patients and ten (60%) non-erythrodermic adults controlled their disease with topical corticosteroids. On the contrary, 26 (68%) erythrodermic patients required biologic therapy as last and effective therapy line requiring an average of 6.5 months to achieve complete response. Conclusion: Our study showed a statistical difference in terms of outcome and response to treatment between children or patients with limited disease and patients who develop erythroderma.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Actas Dermosifiliogr. 2024 Sep;115(8):t761-t5
dc.rights © 2024 AEDV. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.title Pityriasis rubra pilaris: a multicentric case series of 65 spanish patients
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.ad.2024.02.019
dc.subject.keyword Pityriasis rubra pilaris
dc.subject.keyword Biologic agents
dc.subject.keyword Erythroderma
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking